Aminex PLC DIRECTORATE CHANGE (3098F)

TIDMAEX

RNS Number : 3098F

Aminex PLC

13 November 2020

13 November 2020

Aminex plc

("Aminex" or "the Company")

DIRECTORATE CHANGE

Aminex is pleased to announce the appointment of James Lansdell, as a Non-Executive Director of the Company with immediate effect. Mr Lansdell will replace Harald van Dongen, who steps down as a Non-Executive Director.

Under the terms of the Shareholder and Relationship Agreement dated 8 July 2016, Eclipse Investments LLC ("Eclipse") has the right to appoint two directors to the Aminex Board ("Eclipse Directors"). James Lansdell will be proposed for election by shareholders at the next General Meeting of the Company.

James Lansdell is Senior Legal Counsel at The Zubair Corporation. Prior to joining The Zubair Corporation, he was a Senior Associate at Dentons, Muscat. James is an experienced oil and gas and construction lawyer with over 10 years' experience working as a member of Dentons' Tier 1 oil and gas team in London and the Middle East. He is a member of the Association of International Petroleum Negotiators and the Society of Construction Law. He holds an BSc in Psychology and an LLB in Law.

Aminex confirms that there are no matters requiring disclosure in respect of this appointment under paragraph LR9.6.13R of the Listing Rules of the Financial Conduct Authority.

Charles Santos, Chairman of Aminex commented:

"We warmly welcome James to the Board of Aminex and look forward to working with him. On behalf of the Board, we thank Harald for his contribution to the Company and look forward to continuing our working relationship with him through his role with ARA Petroleum."

 
 For further information: 
 
   Aminex PLC                          [phone] 
 Charles Santos, Chairman 
  Robert Ambrose, Chief Executive 
  Officer 
 
 Davy                                   [phone] 
 Brian Garrahy 
 
 Camarco                               [phone] 
 Billy Clegg / James Crothers 
  / Daniel Sherwen 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BOAGPGPWGUPUGWW

(END) Dow Jones Newswires

November 13, 2020 09:00 ET (14:00 GMT)